Cargando…

Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry

BACKGROUND: Obesity is a major risk factor for cardiovascular disease; however, a paradoxical effect of obesity has been reported in patients with heart failure or myocardial infarction. Although several studies have suggested the same obesity paradox in patients undergoing transcatheter aortic valv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Taiyo, Higuchi, Ryosuke, Hagiya, Kenichi, Saji, Mike, Takamisawa, Itaru, Nanasato, Mamoru, Iguchi, Nobuo, Shimizu, Atsushi, Shimizu, Jun, Doi, Shinichiro, Okazaki, Shinya, Sato, Kei, Tamura, Harutoshi, Yokoyama, Hiroaki, Onishi, Takayuki, Tobaru, Tetsuya, Takanashi, Shuichiro, Takayama, Morimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982279/
https://www.ncbi.nlm.nih.gov/pubmed/36873767
http://dx.doi.org/10.1016/j.jacasi.2022.08.014
_version_ 1784900295745077248
author Tezuka, Taiyo
Higuchi, Ryosuke
Hagiya, Kenichi
Saji, Mike
Takamisawa, Itaru
Nanasato, Mamoru
Iguchi, Nobuo
Shimizu, Atsushi
Shimizu, Jun
Doi, Shinichiro
Okazaki, Shinya
Sato, Kei
Tamura, Harutoshi
Yokoyama, Hiroaki
Onishi, Takayuki
Tobaru, Tetsuya
Takanashi, Shuichiro
Takayama, Morimasa
author_facet Tezuka, Taiyo
Higuchi, Ryosuke
Hagiya, Kenichi
Saji, Mike
Takamisawa, Itaru
Nanasato, Mamoru
Iguchi, Nobuo
Shimizu, Atsushi
Shimizu, Jun
Doi, Shinichiro
Okazaki, Shinya
Sato, Kei
Tamura, Harutoshi
Yokoyama, Hiroaki
Onishi, Takayuki
Tobaru, Tetsuya
Takanashi, Shuichiro
Takayama, Morimasa
author_sort Tezuka, Taiyo
collection PubMed
description BACKGROUND: Obesity is a major risk factor for cardiovascular disease; however, a paradoxical effect of obesity has been reported in patients with heart failure or myocardial infarction. Although several studies have suggested the same obesity paradox in patients undergoing transcatheter aortic valve replacement (TAVR), they included a limited number of underweight patients. OBJECTIVES: This study aimed to clarify the effect of being underweight on TAVR outcomes. METHODS: We retrospectively analyzed 1,693 consecutive patients undergoing TAVR between 2010 and 2020. The patients were categorized according to body mass index: underweight (<18.5 kg/m(2); n = 242), normal weight (18.5 to 25 kg/m(2); n = 1,055), and overweight (>25 kg/m(2); n = 396). We compared midterm outcomes after TAVR among the 3 groups; all clinical events were in accordance with the Valve Academic Research Consortium-2 criteria. RESULTS: Underweight patients were more likely to be women and have severe heart failure symptoms, peripheral artery disease, anemia, hypoalbuminemia, and pulmonary dysfunction. They also had lower ejection fractions, smaller aortic valve areas, and higher surgical risk scores. Device failure, life-threatening bleeding, major vascular complications, and 30-day mortality occurred more frequently in underweight patients. The midterm survival rate of the underweight group was inferior to those of the other 2 groups (P < 0.0001; average follow-up, 717 days). In the multivariate analysis, underweight was associated with noncardiovascular mortality (HR: 1.78; 95% CI: 1.16-2.75) but not cardiovascular mortality (HR: 1.28; 95% CI: 0.58-1.88) after TAVR. CONCLUSIONS: Underweight patients had a worse midterm prognosis, demonstrating the obesity paradox in this TAVR population. (Outcomes of transcatheter aortic valve implantation in Japanese patients with aortic stenosis: multi-center registry; UMIN000031133)
format Online
Article
Text
id pubmed-9982279
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99822792023-03-04 Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry Tezuka, Taiyo Higuchi, Ryosuke Hagiya, Kenichi Saji, Mike Takamisawa, Itaru Nanasato, Mamoru Iguchi, Nobuo Shimizu, Atsushi Shimizu, Jun Doi, Shinichiro Okazaki, Shinya Sato, Kei Tamura, Harutoshi Yokoyama, Hiroaki Onishi, Takayuki Tobaru, Tetsuya Takanashi, Shuichiro Takayama, Morimasa JACC Asia Original Research BACKGROUND: Obesity is a major risk factor for cardiovascular disease; however, a paradoxical effect of obesity has been reported in patients with heart failure or myocardial infarction. Although several studies have suggested the same obesity paradox in patients undergoing transcatheter aortic valve replacement (TAVR), they included a limited number of underweight patients. OBJECTIVES: This study aimed to clarify the effect of being underweight on TAVR outcomes. METHODS: We retrospectively analyzed 1,693 consecutive patients undergoing TAVR between 2010 and 2020. The patients were categorized according to body mass index: underweight (<18.5 kg/m(2); n = 242), normal weight (18.5 to 25 kg/m(2); n = 1,055), and overweight (>25 kg/m(2); n = 396). We compared midterm outcomes after TAVR among the 3 groups; all clinical events were in accordance with the Valve Academic Research Consortium-2 criteria. RESULTS: Underweight patients were more likely to be women and have severe heart failure symptoms, peripheral artery disease, anemia, hypoalbuminemia, and pulmonary dysfunction. They also had lower ejection fractions, smaller aortic valve areas, and higher surgical risk scores. Device failure, life-threatening bleeding, major vascular complications, and 30-day mortality occurred more frequently in underweight patients. The midterm survival rate of the underweight group was inferior to those of the other 2 groups (P < 0.0001; average follow-up, 717 days). In the multivariate analysis, underweight was associated with noncardiovascular mortality (HR: 1.78; 95% CI: 1.16-2.75) but not cardiovascular mortality (HR: 1.28; 95% CI: 0.58-1.88) after TAVR. CONCLUSIONS: Underweight patients had a worse midterm prognosis, demonstrating the obesity paradox in this TAVR population. (Outcomes of transcatheter aortic valve implantation in Japanese patients with aortic stenosis: multi-center registry; UMIN000031133) Elsevier 2022-12-13 /pmc/articles/PMC9982279/ /pubmed/36873767 http://dx.doi.org/10.1016/j.jacasi.2022.08.014 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Tezuka, Taiyo
Higuchi, Ryosuke
Hagiya, Kenichi
Saji, Mike
Takamisawa, Itaru
Nanasato, Mamoru
Iguchi, Nobuo
Shimizu, Atsushi
Shimizu, Jun
Doi, Shinichiro
Okazaki, Shinya
Sato, Kei
Tamura, Harutoshi
Yokoyama, Hiroaki
Onishi, Takayuki
Tobaru, Tetsuya
Takanashi, Shuichiro
Takayama, Morimasa
Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title_full Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title_fullStr Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title_full_unstemmed Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title_short Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry
title_sort midterm outcomes of underweight patients undergoing transcatheter aortic valve implantation: insight from the laplace-tavr registry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982279/
https://www.ncbi.nlm.nih.gov/pubmed/36873767
http://dx.doi.org/10.1016/j.jacasi.2022.08.014
work_keys_str_mv AT tezukataiyo midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT higuchiryosuke midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT hagiyakenichi midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT sajimike midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT takamisawaitaru midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT nanasatomamoru midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT iguchinobuo midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT shimizuatsushi midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT shimizujun midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT doishinichiro midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT okazakishinya midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT satokei midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT tamuraharutoshi midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT yokoyamahiroaki midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT onishitakayuki midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT tobarutetsuya midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT takanashishuichiro midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry
AT takayamamorimasa midtermoutcomesofunderweightpatientsundergoingtranscatheteraorticvalveimplantationinsightfromthelaplacetavrregistry